Development of antibody-based vaccines against the trimeric viral envelope spike protein is critical for prevention of HIV-1 infection. Viral sequence diversity, conformational variability and extensive envelope glycosylation have made this a challenging task. With that said, three of the most broadly neutralizing antibodies (BNABs) isolated from human B cells (4E10, 2F5, Z13e1) are directed at the uniquely accessible yet highly conserved segment of gp41 known as the membrane proximal ectodomain region (MPER). While viral-like particles (VLP)-gp41 constructs containing the MPER stimulated strong antibody responses, we observed that their anti-gp41 specificity was preferentially directed at the C-helix and away from the MPER. Consequently, to reduce immunogen complexity, we have recently used NMR and EPR methods to characterize lipid-embedded MPER segments on liposomes, bicelles and micelles prior to and after, BNAB binding. These findings suggest a novel HIV immunization strategy by identifying BNAB triggered conformational alterations in the viral MPER region induced by 4E10 and 2F5 and suggest how these two BNABs perturb function of tryptophan residues therein, critical for fusion pore activity. By contrast, Z13e1 freezes the hinge motion of the helix-hinge-helix MPER segment. Four groups of investigators plan to utilize their collective talents in structural immunology, vaccinology, inflammation research, biomaterials and B cell biology to deliver lipid-embedded MPER nanoparticles for vaccination of animals in order to generate BNABs. The ReinherzA/Vagner groups will analyze structures of HIV MPERs in lipid environments in free- and antibody-bound states, correlating neutralization with antibody-triggered conformational changes around the metastable hinge-linked MPER segment. The Irvine group will create multi-functional MPER nanoparticles consisting of PLGA core particles embedding CD4 T cell epitopes and encapsulated by an outer lipid vesicle or skin for MPER presentation to the immune system via directed targeting to TLRs. The Sitkovskv group will amplify immune responses during vaccination through prevention of downregulation of vaccine-induced inflammation via antagonism of A2AR/A2BR extracellular adenosine receptor-mediated immunosuppression. The Kelsoe group will analyze induction of germinal centers, Ig class switch recombination and hypermutation, affinity maturation of serum antibodies and germinal center B cells in response to MPER immunogens. In conjunction with Projects 1- 3, kinetics of memory B cell and long-lived plasma cell populations will be ascertained and optimized. An Administrative Core with a Partnership Plan is included.

Agency
National Institute of Health (NIH)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI091693-05
Application #
8717558
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Shapiro, Stuart Z
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Moyer, Tyson J; Zmolek, Andrew C; Irvine, Darrell J (2016) Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest 126:799-808
Donius, Luke R; Cheng, Yuxing; Choi, Jaewon et al. (2016) Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity. J Virol 90:8875-90
Song, Likai; Liu, Zhanglong; Kaur, Pavanjeet et al. (2016) Toward increased concentration sensitivity for continuous wave EPR investigations of spin-labeled biological macromolecules at high fields. J Magn Reson 265:188-96
Abbott, Robert K; Thayer, Molly; Labuda, Jasmine et al. (2016) Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination. J Immunol 197:4014-4020
Hanson, Melissa C; Crespo, Monica P; Abraham, Wuhbet et al. (2015) Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest 125:2532-46
Liu, Haipeng; Irvine, Darrell J (2015) Guiding principles in the design of molecular bioconjugates for vaccine applications. Bioconjug Chem 26:791-801
Irvine, Darrell J; Hanson, Melissa C; Rakhra, Kavya et al. (2015) Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem Rev 115:11109-46
Hanson, Melissa C; Abraham, Wuhbet; Crespo, Monica P et al. (2015) Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides. Vaccine 33:861-8
Hatfield, Stephen M; Kjaergaard, Jorgen; Lukashev, Dmitriy et al. (2015) Immunological mechanisms of the antitumor effects of supplemental oxygenation. Sci Transl Med 7:277ra30
Sitkovsky, Michail V; Hatfield, Stephen; Abbott, Robert et al. (2014) Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists. Cancer Immunol Res 2:598-605

Showing the most recent 10 out of 23 publications